FDA Nod For Novartis Drug To Avert Organ Failure In Liver Transplant NASDAQ The approval also means that Zortress (everolimus) is the first mammalian target of rapamycin (mTOR) inhibitor to prevent organ rejection in adult liver transplant patients in the US. The approval was based on positive outcomes from the largest liver ... US FDA okays Novartis drug to prevent liver transplant rejection |
